Literature DB >> 7534069

bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement.

C L Johnston1, H C Cox, J J Gomm, R C Coombes.   

Abstract

Acidic and basic fibroblast growth factors (aFGF and bFGF) are growth factors which may have a physiological role in the normal breast and in breast cancer. A study of the effects of aFGF and bFGF on a variety of breast cell lines and epithelial cells purified from normal breast organoids showed that whereas normal breast cells did not exhibit membrane ruffling in response to either of these growth factors, some breast cancer cell lines did. This difference was not due to lack of receptor since all the cell lines tested were mitogenically stimulated by bFGF. Dominant negative mutations of FGF receptor 3 (FGFR-3) and the small GTP-binding protein p21rac inhibited membrane ruffling, showing that receptor dimerization and phosphorylation and p21rac activation are prerequisites for membrane ruffling in response to aFGF and bFGF. Transient transfection of individual FGFRs into cos-7 cells showed that FGFR-1, FGFR-2 and FGFR-3 could not mediate a membrane ruffling response whereas FGFR-4 could. These studies elucidate one signalling mechanism of FGF and point to differences in the response of normal and cancer breast epithelial cells which may be important in cell motility.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534069      PMCID: PMC1136561          DOI: 10.1042/bj3060609

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  55 in total

Review 1.  The heparin-binding (fibroblast) growth factor family of proteins.

Authors:  W H Burgess; T Maciag
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

2.  Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins.

Authors:  D Bar-Sagi; J R Feramisco
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

Review 3.  Fibroblast growth factor: structural and biological properties.

Authors:  D Gospodarowicz; G Neufeld; L Schweigerer
Journal:  J Cell Physiol Suppl       Date:  1987

Review 4.  Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis.

Authors:  D Moscatelli; D B Rifkin
Journal:  Biochim Biophys Acta       Date:  1988-08-03

5.  Novel tyrosine kinase identified by phosphotyrosine antibody screening of cDNA libraries.

Authors:  S Kornbluth; K E Paulson; H Hanafusa
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

6.  Growth stimulation of human breast epithelial cells by basic fibroblast growth factor in serum-free medium.

Authors:  K Takahashi; K Suzuki; S Kawahara; T Ono
Journal:  Int J Cancer       Date:  1989-05-15       Impact factor: 7.396

7.  Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor.

Authors:  P L Lee; D E Johnson; L S Cousens; V A Fried; L T Williams
Journal:  Science       Date:  1989-07-07       Impact factor: 47.728

8.  Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.

Authors:  K P Karey; D A Sirbasku
Journal:  Cancer Res       Date:  1988-07-15       Impact factor: 12.701

9.  Identification of a pituitary factor responsible for enhancement of plasminogen activator activity in breast tumor cells.

Authors:  R Mira-y-Lopez; J Joseph-Silverstein; D B Rifkin; L Ossowski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

10.  Induction of circular membrane ruffling on human fibroblasts by platelet-derived growth factor.

Authors:  K Mellström; C H Heldin; B Westermark
Journal:  Exp Cell Res       Date:  1988-08       Impact factor: 3.905

View more
  13 in total

1.  Cell volume measurement using scanning ion conductance microscopy.

Authors:  Y E Korchev; J Gorelik; M J Lab; E V Sviderskaya; C L Johnston; C R Coombes; I Vodyanoy; C R Edwards
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

2.  Loss of heterozygosity and DNA methylation affect germline fibroblast growth factor receptor 4 polymorphism to direct allelic selection in breast cancer.

Authors:  Xuegong Zhu; Lei Zheng; Sylvia L Asa; Shereen Ezzat
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

3.  Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: a severe form of human achondroplasia.

Authors:  Changsheng Guo; Catherine R Degnin; Melanie B Laederich; Gregory P Lunstrum; Paul Holden; Jeanie Bihlmaier; Deborah Krakow; Yoon-Jae Cho; William A Horton
Journal:  Cell Signal       Date:  2008-04-10       Impact factor: 4.315

4.  Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis.

Authors:  Shereen Ezzat; Lei Zheng; Xian-Feng Zhu; Gillian E Wu; Sylvia L Asa
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

5.  Fibroblast growth factor receptor 4 (FGFR4) is expressed in adult rat and human retinal photoreceptors and neurons.

Authors:  V Fuhrmann; N Kinkl; T Leveillard; J Sahel; D Hicks
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

6.  The location of acidic fibroblast growth factor in the breast is dependent on the activity of proteases present in breast cancer tissue.

Authors:  R C Coope; P J Browne; C Yiangou; G S Bansal; J Walters; N Groome; S Shousha; C L Johnston; R C Coombes; J J Gomm
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance.

Authors:  C Yiangou; J J Gomm; R C Coope; M Law; Y A Luqmani; S Shousha; R C Coombes; C L Johnston
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Down-regulation of a novel form of fibroblast growth factor receptor 1 in human breast cancer.

Authors:  C Yiangou; H Cox; G S Bansal; R Coope; J J Gomm; R Barnard; J Walters; N Groome; S Shousha; R C Coombes; C L Johnston
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis.

Authors:  Chang-Hwan Yeom; Gunsup Lee; Jin-Hee Park; Jaelim Yu; Seyeon Park; Sang-Yeop Yi; Hye Ree Lee; Young Seon Hong; Joosung Yang; Sukchan Lee
Journal:  J Transl Med       Date:  2009-08-11       Impact factor: 5.531

10.  Expression of fibroblast growth factor 1 is lower in breast cancer than in the normal human breast.

Authors:  G S Bansal; C Yiangou; R C Coope; J J Gomm; Y A Luqmani; R C Coombes; C L Johnston
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.